Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior
Christopher J. Schwartz(University of California, San Francisco), Gregor Krings(Cleveland Clinic), Timothy W. Jacobs(Jacobs (United States)), Rita A. Mukhtar(University of California, San Francisco), Yunn‐Yi Chen(University of Vermont), Gregory R. Bean(Stanford University), Elizabeth M. Hosfield(University of Virginia), Nancy M. Joseph(University of California, San Francisco), Deepika Sirohi(University of Utah), Jeanette Ruiz(University of California, San Francisco)
Cited by 26
Related Papers
Comprehensive analysis of normal adjacent to tumor transcriptomes
|Nature Communications|2017|663
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
|Nature Medicine|2016|539
Specificity of HercepTest in Determining <i>HER-2</i>/<i>neu</i> Status of Breast Cancers Using the United States Food and Drug Administration–Approved Scoring System
|Journal of Clinical Oncology|1999|459
Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction
|Circulation|2008|454